Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses

Saskia Räuber1,2, Michael Heming1, Jonathan Repple3

  • 1Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.

Molecular Psychiatry
|August 7, 2021
PubMed

Insights

This study reveals immune cell differences in blood and cerebrospinal fluid (CSF) of psychosis patients. Machine learning models using these immune signatures can aid in diagnosing psychosis spectrum disorders.

Area of Science:

  • Neuroimmunology
  • Psychiatry
  • Immunology

Background:

  • Psychotic disorders are prevalent and debilitating, yet the role of immune mechanisms remains debated.
  • Understanding immune profiles in psychosis is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate immune cell profiles in blood and cerebrospinal fluid (CSF) of psychosis spectrum patients.
  • To evaluate the diagnostic potential of immune signatures using machine learning.

Main Methods:

  • Retrospective analysis of blood and CSF immune cell profiles from 59 psychosis patients.
  • Multi-dimensional flow cytometry and basic CSF analysis.
  • Comparison with inflammatory and non-inflammatory control groups.

Main Results:

  • Confirmed monocyte expansion in psychosis patients' blood, specifically classical monocytes.
  • Observed a shift towards monocytes in CSF, elevated protein levels, and blood-brain barrier disruption.
  • Machine learning models integrating blood and CSF parameters showed superior psychosis differentiation.

Conclusions:

  • Immune cell signatures in multiple body compartments can support psychosis spectrum disorder diagnosis.
  • These findings may accelerate diagnosis and treatment initiation for psychosis.
  • CSF immune profiles distinguish psychosis from autoimmune encephalitis with similar initial symptoms.